Thomsen, F. B., Røder, M. A., Jakobsen, H.
, Langkilde, N. C., Borre, M., Jakobsen, E. B., Frey, A., Lund, L., Lunden, D., Dahl, C. & Brasso, K. (2019).
Active Surveillance Versus Radical Prostatectomy in Favorable-risk Localized Prostate Cancer.
Clinical Genitourinary Cancer,
17(4), e814-e821.
https://doi.org/10.1016/j.clgc.2019.05.005Fredsøe, J., Rasmussen, A. K. I., Mouritzen, P.
, Borre, M., Ørntoft, T. & Sørensen, K. D. (2019).
A five-microRNA model (pCaP) for predicting prostate cancer aggressiveness using cell-free urine.
International Journal of Cancer,
145(9), 2558-2567.
https://doi.org/10.1002/ijc.32296
Strand, S. H., Bavafaye-Haghighi, E., Kristensen, H., Rasmussen, A. K., Hoyer, S., Borre, M., Mouritzen, P.
, Besenbacher, S., Orntoft, T. F. & Sorensen, K. D. (2019).
A novel combined miRNA and methylation marker panel (miMe) for prediction of prostate cancer outcome after radical prostatectomy.
International Journal of Cancer,
145(12), 3445-3452.
https://doi.org/10.1002/ijc.32427
Lohmann, S., Eijken, M., Møldrup, U., Møller, B. K., Hunter, J., Moers, C., Ploeg, R. J., Baan, C. C.
, Jespersen, B. & Keller, A. K. (2019).
A Pilot Study of Postoperative Animal Welfare as a Guidance Tool in the Development of a Kidney Autotransplantation Model With Extended Warm Ischemia.
Transplantation Direct,
5(11), Artikel e495.
https://doi.org/10.1097/TXD.0000000000000941
Bjerre, E. D., Petersen, T. H., Jørgensen, A. B., Johansen, C., Krustrup, P.
, Langdahl, B., Poulsen, M. H., Madsen, S. S., Østergren, P. B.
, Borre, M., Rørth, M., Brasso, K. & Midtgaard, J. (2019).
Community-based football in men with prostate cancer: 1-year follow-up on a pragmatic, multicentre randomised controlled trial.
PLOS Medicine,
16(10), Artikel e1002936.
https://doi.org/10.1371/journal.pmed.1002936Vind-Kezunovic, S., Bouchelouche, K., Ipsen, P., Høyer, S., Bell, C. & Bjerggaard Jensen, J. (2019).
Detection of Lymph Node Metastasis in Patients with Bladder Cancer using Maximum Standardised Uptake Value and 18F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography: Results from a High-volume Centre Including Long-term Follow-up.
European Urology Focus,
5(1), 90-96.
https://doi.org/10.1016/j.euf.2017.06.005
Christensen, E., Birkenkamp-Demtröder, K., Sethi, H., Shchegrova, S., Salari, R.
, Nordentoft, I., Wu, H.-T.
, Knudsen, M., Lamy, P., Lindskrog, S. V., Taber, A., Balcioglu, M.
, Vang, S., Assaf, Z., Sharma, S., Tin, A. S., Srinivasan, R., Hafez, D.
, Reinert, T. ... Dyrskjøt, L. (2019).
Early Detection of Metastatic Relapse and Monitoring of Therapeutic Efficacy by Ultra-Deep Sequencing of Plasma Cell-Free DNA in Patients With Urothelial Bladder Carcinoma.
Journal of Clinical Oncology,
37(18), 1547-1557.
https://doi.org/10.1200/JCO.18.02052
Laursen, E. B., Fredsøe, J., Schmidt, L., Strand, S., Kristensen, H., Ildor Rasmussen, A. K.
, Daugaard, T. F., Mouritzen, P.
, Høyer, S., Kristensen, G., Stroomberg, H. V., Brasso, K., Røder, M. A.
, Borre, M. & Sørensen, K. D. (2019).
Elevated miR-615-3p Expression Predicts Adverse Clinical Outcome and Promotes Proliferation and Migration of Prostate Cancer Cells.
The American Journal of Pathology,
189(12), 2377-2388.
https://doi.org/10.1016/j.ajpath.2019.08.007
Nørgaard, M., Haldrup, C., Bjerre, M. T., Høyer, S., Ulhøi, B., Borre, M. & Sørensen, K. D. (2019).
Epigenetic silencing of MEIS2 in prostate cancer recurrence.
Clinical Epigenetics,
11(1), 147. Artikel 147.
https://doi.org/10.1186/s13148-019-0742-x
Ernst, A., Brix, N., Lauridsen, L. L. B., Olsen, J., Parner, E. T., Liew, Z., Olsen, L. H. & Ramlau-Hansen, C. H. (2019).
Exposure to Perfluoroalkyl Substances during Fetal Life and Pubertal Development in Boys and Girls from the Danish National Birth Cohort.
Environmental Health Perspectives,
127(1), Artikel 17004.
https://doi.org/10.1289/EHP3567
Bjerre, E. D., Brasso, K., Jørgensen, A. B., Petersen, T. H., Eriksen, A. R., Tolver, A., Christensen, J. F., Poulsen, M. H.
, Madsen, S. S., Østergren, P. B.
, Borre, M., Krustrup, P., Johansen, C., Rørth, M. & Midtgaard, J. (2019).
Football Compared with Usual Care in Men with Prostate Cancer (FC Prostate Community Trial): A Pragmatic Multicentre Randomized Controlled Trial.
Sports Medicine,
49(1), 145-158.
https://doi.org/10.1007/s40279-018-1031-0Jochumsen, M. R., Bouchelouche, K., Nielsen, K. B., Borre, M., Frøkiær, J., Sørensen, J. & Tolbod, L. P. (2019).
High repeatability of dynamic 82Rubidium-PET/CT for tumor blood flow imaging in prostate cancer - a test-retest study.
European Journal of Nuclear Medicine and Molecular Imaging,
46(Suppl 1), S278-S279. Artikel OP-728.
https://doi.org/10.1007/s00259-019-04486-2
Villumsen, B. R., Jorgensen, M. G.
, Frystyk, J., Hordam, B.
& Borre, M. (2019).
Home-based ‘exergaming’ was safe and significantly improved 6-min walking distance in patients with prostate cancer: a single-blinded randomised controlled trial.
BJU International,
124(4), 600-608.
https://doi.org/10.1111/bju.14782